2016 / 06

Next Paper
DOI: 10.24075/brsmu.2016-06-08
Copyright: © 2017 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Clinical and laboratory features of hemostatic disorders in patients with retinal vein occlusion

Shelkovnikova TV1,2, Takhchidi KhP3, Volkov AN4, Shishlyannikova NYu
About authors

1 Novokuznetsk State Institute of Further Training of Physicians, Novokuznetsk, Russia

2 Kemerovo Regional Clinical Ophthalmological Hospital, Kemerovo, Russia

3 Pirogov Russian National Research Medical University, Moscow, Russia

4 Kemerovo Regional Clinical Hospital, Kemerovo, Russia

5 Kemerovo State Medical University, Kemerovo, Russia

Correspondence should be addressed: Tatiana Shelkovnikova
Pionerskiy bulvar, d. 10a, kv. 1, Kemerovo, Russia, 650066; moc.liamg@avokinvoklehs.t

Received: 2016-11-28 Accepted: 2016-12-10 Published online: 2017-01-19
|
  1. Krylova AA, Zapuskalov IV, Krivosheina OI. [Etiology and pathogenesis of retinal vein occlusion: the actual state of a problem]. Byulleten' sibirskoi meditsiny. 2015; 14 (2): 82–90. Russian.
  2. Astakhov IuS, Petrishchev NN, Varganova TS, Tul'tseva SN. [Thrombophilia in the pathogenesis of retinal vein thrombosis]. Vestn Oftalmol. 2008 May–Jun; 124 (3): 56–9. Russian.
  3. Tul'tseva SN, Astakhov YuS. Okklyuzii ven setchatki (etiologiya, patogenez, klinika, diagnostika, lechenie). St. Petersburg: Izdatel'stvo “N-L”; 2010. 112 p. Russian.
  4. Kobilyanskaya VA. Rezistentnost' k aktivirovannomu proteinu S — prichina nasledstvennoi i priobretennoi trombofilii. Uchenye zapiski SPbGMU imeni akademika IP Pavlova. 2004; 11 (3 Suppl): 20–5. Russian.
  5. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med. 2011 Jan; 13 (1): 67–76.
  6. Dhôte R, Bachmeyer C, Horellou MH, Toulon P, Christoforov B. Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol. 1995 Sep; 120 (3): 388–9.
  7. Papayan LP, Kobilyanskaya VV, Shitikova AS. Obshchie printsipy diagnostiki antifosfolipidnogo sindroma. Uchenye zapiski SPbGMU imeni akademika IP Pavlova. 2004; 11 (3 Suppl): 59– 62. Russian.
  8. Papayan KA, Savenkova ND. [Antiphospholipid syndrome in practice of pediatric nephrologist]. Tromboz, gemostaz i reologia. 2014; 58 (2): 9–15. Russian.
  9. Smirnova TV. [Ophthalmological manifestations of the antiphospholipid syndrome]. Vestn Oftalmol. 2007 Mar–Apr; 123 (2): 49–53. Russian.
  10. Shelkovnikova TV, Takhchidi KhP, Katsadze YL, Vavin GV, Shishlyannikova NY. [Clinical and laboratory diagnostics of disorders in hemostatic system in patients with retinal vein occlusion]. Meditsinskii alfavit. 2015; 3 (21): 44–7. Russian.
  11. Shelkovnikova TV, Takhchidi KhP, Korshunov GV, Katsad- ze YuL, Shishlyannikova NYu. Retinal'nyi trombogemorragicheskii sindrom u patsientov s narusheniyami v sisteme gemostaza na fone sakharnogo diabeta II tipa. Meditsinskii alfavit. 2015; 2 (8): 39–42. Russian.